Predictors of hospital discharge and mortality in patients with diabetes and COVID-19: updated results from the nationwide CORONADO studySamy Hadjadj, B. Delenne, Delphine Demarsy et al.|Diabetologia|2021Cited by 168
Use of dipeptidyl peptidase‐4 inhibitors and prognosis of <scp>COVID</scp> ‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the <scp>CORONADO</scp> studyRonan Roussel, Patrice Darmon, Matthieu Pichelin et al.|Diabetes Obesity and Metabolism|2021Cited by 36
Sex disparities in COVID-19 outcomes of inpatients with diabetes: insights from the CORONADO studyBlandine Tramunt, Pierre Gourdy, Sarra Smati et al.|European Journal of Endocrinology|2021Cited by 18
Initiation of the Fixed Combination IDegLira in Patients with Type 2 Diabetes on Prior Injectable Therapy: Insights from the EASY French Real-World StudyBlandine Tramunt, Pierre Gourdy, Emmanuel Disse et al.|Diabetes Therapy|2022Cited by 5
Association fixe Degludec-Liraglutide en situation de vie réelle : étude multicentrique française sur les modalités dâinitiation et lâefficacité à 6 moisChloé Noilhan, Pierre Gourdy, L. Cazals et al.|Unknown|2019Cited by 0